03/18/2025
4:15 PM | Anika Therapeutics (Issuer)
Blanchard Cheryl R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
4:16 PM | Anika Therapeutics (Issuer)
Colleran David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
4:16 PM | Anika Therapeutics (Issuer)
Griffin Stephen D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
4:16 PM | Anika Therapeutics (Issuer)
Nunes Anne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2025
4:15 PM | Anika Therapeutics (Issuer)
Blanchard Cheryl R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2025
4:18 PM | Anika Therapeutics (Issuer)
Colleran David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2025
4:19 PM | Anika Therapeutics (Issuer)
Nunes Anne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
7:00 AM | Anika Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/23/2025
2:55 PM | Anika Therapeutics (Subject)
DIMENSIONAL FUND ADVISORS LP (Filed by)
| Form SCHEDULE 13G/A | |
11/08/2024
1:17 PM | Anika Therapeutics (Subject)
BlackRock, Inc. (Filed by)
| Form SC 13G/A | |
11/04/2024
3:41 PM | Anika Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
Get the Latest News and Ratings for ANIK and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Anika Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
10/31/2024
6:20 AM | Anika Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/31/2024
6:16 AM | Anika Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2024
3:06 PM | Anika Therapeutics (Issuer)
Nunes Anne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2024
4:21 PM | Anika Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/11/2024
3:35 PM | Anika Therapeutics (Issuer)
VOGT SUSAN L N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2024
3:31 PM | Anika Therapeutics (Issuer)
Capper Joseph H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2024
3:32 PM | Anika Therapeutics (Issuer)
CONLEY SHERYL L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2024
3:32 PM | Anika Therapeutics (Issuer)
Fischetti Gary P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2024
3:33 PM | Anika Therapeutics (Issuer)
HENNEMAN JOHN B III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2024
3:33 PM | Anika Therapeutics (Issuer)
Jellison William R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2024
3:34 PM | Anika Therapeutics (Issuer)
Larsen Glenn R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2024
3:34 PM | Anika Therapeutics (Issuer)
Richard Stephen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
3:24 PM | Anika Therapeutics (Filer)
| Form DEFA14A | |
06/05/2024
3:10 PM | Anika Therapeutics (Issuer)
Capper Joseph H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
3:10 PM | Anika Therapeutics (Issuer)
Griffin Stephen D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
3:11 PM | Anika Therapeutics (Issuer)
Jellison William R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2024
3:31 PM | Anika Therapeutics (Subject)
Caligan Partners LP (Filed by)
| Form SC 13D/A | |
05/28/2024
4:04 PM | Anika Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2024
4:15 PM | Anika Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/08/2024
3:12 PM | Anika Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/26/2024
7:48 AM | Anika Therapeutics (Filer)
| Form 10-K/A | |
04/05/2024
11:21 AM | Anika Therapeutics (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G/A | |
